MEDU-16. MYC BUT NOT MYCN GENERATES AGGRESSIVE GROUP 3 MEDULLOBLASTOMA THROUGH ARF SUPPRESSION

Group 3 medulloblastoma (MB) carry the worst prognosis of all MB. The transcription factors MYC and MYCN are suggested drivers for a subset of these tumours; with MYC amplifications (17–20%) representing the most common genetic alteration in Group 3 tumours, while MYCN amplifications (4–6%) are less...

Full beskrivning

Sparad:
Bibliografiska uppgifter
I publikationen:Neuro Oncol
Huvudupphovsmän: Mainwaring, Oliver, Weishaupt, Holger, Hutter, Sonja, Rosen, Gabriela, Annusver, Karl, Kasper, Maria, Swartling, Fredrik
Materialtyp: Artigo
Språk:Inglês
Publicerad: Oxford University Press 2019
Ämnen:
Medulloblastoma
Länkar:https://ncbi.nlm.nih.gov/pmc/articles/PMC6477231/
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1093/neuonc/noz036.175
Taggar: Lägg till en tagg
Inga taggar, Lägg till första taggen!

Liknande verk